Circulating Cytokines as Biological Indicators for PE and Ceramics Articulations


Article Preview

We studied the role of cytokines (TNF-α, IL-6,IL-1β, TGF-β) as markers of osteolysis in patients who underwent to a hip prosthesis implantation subdivided in two groups: group A with an ultrahigh molecular weight polyethylene (UHMWPE) insert articulating against a metal ball head , and group B with an all alumina ceramic combination. Profibrogenic (TGF-β) and pro-inflammatory cytokines (TNF-α, IL-6,IL-1β) are secreted by the periprosthetic synovial-like fibrous membrane in hip artificial implants. They are secreted by inflammatory activated cells and trigger the cascade of biochemical events leading to the activation of osteoclasts and bone resorption. A statistically significant increase of TGF-β serum levels was observed between TGF-β values in implanted patients as compared to normal subjects and between TGF-β values after versus before implantation in Group A. A progressive decrease in TNF-α and IL-6 serum levels has been observed in both Groups, when compared with the initial values before the implantation. IL-1β levels decreased up to 60 months after the implantation Our data suggest that monitoring circulating cytokines could be a good indicator for the proliferation and activity of the periprosthetic synovial-like membrane and potential osteolysis. This could allow for an adequate early treatment.



Key Engineering Materials (Volumes 361-363)

Main Theme:

Edited by:

Guy Daculsi and Pierre Layrolle




S. Fiorito et al., "Circulating Cytokines as Biological Indicators for PE and Ceramics Articulations", Key Engineering Materials, Vols. 361-363, pp. 1323-1326, 2008

Online since:

November 2007




[1] D.R. Haynes, T.N. Crotti, H. Zreiqat: Biomaterials vol. 25 (2004), p.4877.

[2] L.C. Jones, C. Frondoza, D.S. Hungerford: J. Biomed. Mater. Res. vol. 48 (1999), p.889.

[3] W.H. Harris: Clin. Orthop. Relat. Res. vol 393 (2001), p.66.

[4] Y.T. Konntinen, D. Zhao, A. Beklen, G. Ma, M. Takagi, M. Kivela-Rajamaki, N. Ashammakhi, S. Santavirta: Clin. Orthop. Relat. Res. vol 430 (2005), p.28.

[5] S. Fiorito, L. Magrini, C. Goalard: J. Bone J. Surg. Br vol 85 (2003), p.1202.

[6] L.F. Bonewald, S.L. Dallas: J. Cell. Biochem. Vol 55 (1994), p.350.

[7] J.M.W. Quinn, K. Itoh, N. Udagawa, K. Hausler, et al: J. Bone Miner. Res. vol 16 (2001), p.1787.

[8] M.F. Pilkington, S.M. Sims, S.J. Dixon: J. Bone Miner. Res. vol 16 (2001), p.1237.

[9] P. Palmqvist, E. Persson, H.H. Conaway, U.H. Lerner: J. Immunol. vol 169 (2002), p.3353.

[10] S. Kwan Tat, M. Padrines, S. Thaeoleyre, D. Heymann, Y. Fortun: Cytokine Growth Factor Rev. vol 15 (2004), p.49.


[11] P.A. Campbell, M. Wang, H.C. Amstutz, S.B. Goodman: Acta Orthop. Scand. vol 73 (2002), p.506.

[12] S.G. Sun, B.A. Ma, Y. Zhaou, M.H. Zhang, Q.Y. Fan: Acta Orthop. vol 77 (2006), p.320.

[13] E. Cenni, L. Savarino, D. Antonioli, A. Pellacani, A. Giunti, M. Baldini: Acta Orthop. vol 76 (2005), p.61.

[14] M. Takagi, S. Santavirta, H. Ida, M. Ishii, I. Takei, S. Niissalo, T. Ogino, Y.T. Konttinen: J. Bone Miner. Res. vol 16 (2001), p.79.